Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H44O3 |
Molecular Weight | 416.6365 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@]5([H])C[C@@H](O)CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@@]6(CC[C@H](C)CO6)O2
InChI
InChIKey=GMBQZIIUCVWOCD-WWASVFFGSA-N
InChI=1S/C27H44O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28H,5-15H2,1-4H3/t16-,17-,18+,19-,20+,21-,22-,23-,24-,25-,26-,27+/m0/s1
Molecular Formula | C27H44O3 |
Molecular Weight | 416.6365 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 11 / 12 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
PYM50018 (also known as Myogane or SARSAGENIN) has demonstrated neuroprotective effects in several preclinical models. It was observed that PYM50018 protects against neuronal damage, increases neurite outgrowth, reverses oxidative damage and reversed neuronal apoptosis. PYM50018 is in phase I clinical study for the treatment of amyotrophic lateral sclerosis (ALS).
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:56:57 GMT 2023
by
admin
on
Sat Dec 16 17:56:57 GMT 2023
|
Record UNII |
CFS802C28F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C823
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/08/543
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
||
|
FDA ORPHAN DRUG |
185704
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CFS802C28F
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
9639
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
1615
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
m9787
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID00903921
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
C152305
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
204-776-3
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
15578
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
126-19-2
Created by
admin on Sat Dec 16 17:56:57 GMT 2023 , Edited by admin on Sat Dec 16 17:56:57 GMT 2023
|
PRIMARY | |||
|
92095
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
100000177287
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY | |||
|
SARSASAPOGENIN
Created by
admin on Sat Dec 16 17:56:58 GMT 2023 , Edited by admin on Sat Dec 16 17:56:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|